Drug class
Benzodiazepine hypnotic; positive allosteric modulator of GABAA receptors
Mechanism of action
Enhances GABA-mediated inhibitory neurotransmission through positive allosteric modulation of GABAA receptor complexes at the benzodiazepine binding site, producing sedative and hypnotic effects.
General use cases
- Short-term treatment of insomnia in countries where cinolazepam is authorised; use is limited by sedation, tolerance, dependence and withdrawal risk
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
